Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

January 22, 2018 Cover

Volume 96, Issue 4

FDA approvals hit a 20-year high in 2017, with cancer and rare-disease drugs dominating the list of new medicines

Cover image:

Full Article
Volume 96 | Issue 4

All Issues

The year in new drugs

FDA approvals hit a 20-year high in 2017, with cancer and rare-disease drugs dominating the list of new medicines

  • Weed scientists brace for a second year of dicamba use

    Drifty pesticide caused damage and controversy last year, but new restrictions may help

  • Peptide makers face threat from biotechnology

    How a 1-year-old German start-up could be about to shake up a $1 billion market

  • Shell buys stake in solar developer Silicon Ranch

    Firm is among European oil and gas firms turning to renewables to diversify earnings sources

ADVERTISEMENT
image name
Materials

Grain boundaries impede ion conduction in solid-state Li-ion batteries

Simulations quantify performance of solid-state replacements for flammable liquids in Li-ion batteries

ADVERTISEMENT
ADVERTISEMENT